Clinical Trials Logo
  1. Home
  2. Poliomyelitis
  3. NCT05303545
  4. Details
NCT05303545 Clinical Trial

Physical Activity in People With Sequelae of Poliomyelitis

Poliomyelitis Clinical Trial

Official title:
Physical Activity in People With Sequelae of Poliomyelitis : a Cross-sectional Study

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05303545
Other study ID # 2022-003
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 1, 2022
Est. completion date December 1, 2023

Study information
Verified date January 2023
Source Institut de Sante Parasport Connecte Synergies
Contact François Genêt, MD-PhD
Phone +33 1 47 10 70 82
Email francois.genet@aphp.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

People with disabilities are less physically active than the general population. At present, the physical activity level of people with poliomyelitis sequelae and their barriers to physical activity are unknown. The aim of this study is to describe the physical activity level of people with poliomyelitis sequelae and their barriers to physical activity.

Description:

This is a cross-sectional, monocentric, cohort study of subjects with poliomyelitis sequelae followed in a Physical Medicine and Rehabilitation Department. All consecutive eligible outpatient subjects consulting to the Physical Medicine and Rehabilitation Department of our university hospital will be included. Data will be collected from the patients' medical records, in particular data related to their clinical, radiological, biological and physiological examinations. It is an ancillary study to the NO-AGING study.

Recruitment information / eligibility
Status Recruiting
Enrollment 200
Est. completion date December 1, 2023
Est. primary completion date October 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Consulting to the Physical Medicine and Rehabilitation Department of our university hospital - Having poliomyelitis sequelae - No opposition to be enrolled in the study from the patient - Affiliation to a social security scheme Exclusion Criteria: - Disability that does not allow the completion of questionnaires - Acute intercurrent medical situation - Use of electric wheelchair - Under court protection.

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• standard of care for patients with poliomyelitis sequelae
clinical examination, radiological, biological and physiological examinations.

Locations
Country Name City State
France Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP Garches

Sponsors (2)
Lead Sponsor Collaborator
Institut de Sante Parasport Connecte Synergies Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Physical activity level Physical Activity Scale for Individuals with Physical Disabilities (PASIPD) Questionnaire Baseline
Secondary Barriers of physical activity Barriers to Physical Activity Questionnaire for People with Mobility Impairments (BPAQ-MI) Baseline
See also
  Status Clinical Trial Phase
Completed NCT04989231 - An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses
Completed NCT00352963 - Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). Phase 3
Recruiting NCT03890497 - Assessment of Poliovirus Type 2 Immunogenicity of One and Two Dose Schedule With IPV and fIPV When Administered at 9-13 Months of Age in Bangladesh Phase 4
Completed NCT00753649 - Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants Phase 4
Completed NCT04693286 - Clinical Trial of Novel OPV2 Vaccine Phase 2
Completed NCT02847026 - Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study Phase 4
Completed NCT02189811 - Polio End-game Strategies - Poliovirus Type 2 Challenge Study Phase 4
Completed NCT01444781 - Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants Phase 3
Completed NCT01214889 - Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants. Phase 3
Completed NCT00879827 - Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants Phase 3
Completed NCT01457495 - Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly Phase 2
Completed NCT02853929 - Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery Phase 4
Completed NCT03614702 - Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV Phase 3
Terminated NCT04063150 - Immunogenicity of Intramuscular and Intradermal IPV Phase 4
Completed NCT04614597 - A Study on Immunity Duration Against Polio Over 18 Months Infants After 2 or 3 Primary Doses Sabin IPV in China
Completed NCT03239496 - A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV Phase 3
Completed NCT04544787 - A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates Phase 2
Completed NCT02985320 - Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine Phase 1/Phase 2
Completed NCT02291263 - Immunogenicity of Intramuscular Inactivated Poliovirus Vaccine Phase 3
Completed NCT02274285 - DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants Phase 3